Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

anti-IGF1R recombinant monoclonal antibody MK-0646

(AN-tee … ree-KOM-bih-nunt MAH-noh-KLOH-nul AN-tee-BAH-dee …)
A substance being studied in the treatment of many types of cancer. Anti-IGF1R recombinant monoclonal antibody MK-0646 binds to a protein called insulin-like growth factor receptor (IGFR) on the surface of cells. This may prevent the cells from growing when IGF is present. It may also kill cancer cells. Anti-IGF1R recombinant monoclonal antibody MK-0646 is a type of monoclonal antibody. Also called MK-0646.
Search NCI's Dictionary of Cancer Terms